Convergence Investment Partners’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,577
Closed -$187K 252
2020
Q4
$187K Buy
+2,577
New +$149K 0.09% 191

Other funds holding CDNA

Convergence Investment Partners's CDNA Position: Q1 2021 in Review

Convergence Investment Partners sold out of CareDx (CDNA) in Q1 2021, closing a stake of 2,577 shares — an estimated $187K sold.

Convergence Investment Partners first reported a position in CDNA in Q4 2020 and held it in 1 quarter. The position peaked at $187K in Q4 2020. 245 funds tracked by Wall St. Rank hold CDNA as of Q1 2021.

  • Convergence Investment Partners reported no remaining CareDx position as of Q1 2021 after selling out during the quarter.
  • Convergence Investment Partners sold 2,577 CareDx shares in Q1 2021, an estimated $187K.
  • Convergence Investment Partners first reported a position in CareDx in Q4 2020 and held it in 1 quarter.
  • Convergence Investment Partners's CareDx position peaked at $187K in Q4 2020.
  • 245 funds tracked by Wall St. Rank held CareDx as of Q1 2021.

Based on Convergence Investment Partners's 13F filing for Q1 2021, filed 30 Apr 2021.